Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
gen med terms
| TERM | DEFINITION |
|---|---|
| myocardium | muscle that makes up the heart |
| endocardium | c.t. that encloses the entire heart |
| pericardium | attaches the endocardium to the thorax |
| coronary arteries | branch from the base of the aorta to supply the entire myocardium |
| systole | contraction phase |
| diastole | atria and ventricles relaxed |
| stroke volume | amount of blood pumped into aorta during a single ventricular contraction |
| cardiac output | stroke volume x heart rate: volume of blood pumped per minute |
| erythrocytes (rbc) | transport o2 remove co2 |
| leukocytes (wbc) | phagocytosis, mediate immune system response |
| thrombocytes (platelets) | clotting |
| blood pressure | pressure of blood against arterial walls, maintains perfusion of o2 into organs |
| myocardial ischemia | myocardium deprived of oxygen resulting in chest pain (angina) |
| dyspnea | shortness of breath; occurs when cardiac output decreases |
| fatigue | reduction in the body's capability to perform work |
| palpitation | senseation of skipped beats or the heart fluttering uncomfortably |
| arrhythmia | disturbance of the electrical activity that controls the heartbeat which causes cardiac contractions of excessive pace or strenght (palpitations) |
| claudication | impaired gait, occurs when blood flow to a lower limb is blocked |
| edema | abnormal accumulation of fluid in the interstitial spaces, occurs with chronic cardiac conditions or obstruction of veins or lymph vessels |
| Korotkoff sounds | sounds used to determine bp |
| atherosclerosis | arteries that have been pathologically narrowed |
| aneurysm | deformed arteries |
| athletes heart | general cardiac hypertrophy- enlargmenet of both ventricles due to adaptation to strenuous aerobic exercise |
| hypertrophic cardiomyopathy | pathological enlrgment of the heart associated with an asymmetricl enlrgment of the left ventricular cavity-leading cause of SCD in young athletes |
| myocardial ischemia | oxygen needed by myocardium exceeds oxygen in blood delivered by the coronary arteries |
| arrhythmogenic right ventricular dysplasia (ARVD) | fatty infiltration (penetration) and fibrosis of the myocardium of the right ventricle |
| Mitral valve prolapse (MVP) | deformity of mitral valve leaflets that prevents it from closing completely |
| paroxysmal Supraventricular Tachycardia | intermittently occuring very rapid heart rate at rest >150 bpm- defect in discharge pattern of SA node, atria, or AV node that causes drastic increase in heart rate |
| Q-T interval | time it takes for ventricles to depolarize and repolarize |
| Wolfe-parkinson-White Syndrome | accessory pathway between atria and ventricles conducts more rapidlyithan the AV node, and result is that one of the ventricles depolarizes slightly before the other |
| marfan Syndrome | Connective tissue disorder associated with increased risk for scd, develop potentially fatal deformities in aorta |
| Commotio Cordis | Sudden blows to the chest that occur during the vulnerable phase of cardiac repolarization that induce a severe ventricular arrhytmia |
| myocarditis | inflammatory process of the cardiac muscle cells |
| generic drug | copy of brand name drug whose patents have expired can sell for cheaper bc no experimental cost |
| enteral routes | routes of admin that provide entry to the boyd by way of alimentary canal or digestive system (oral, rectal) |
| parenteral routes | injection inhalation sublingual buccal and topical |
| enteric coating | delays the release of medication until it reaches small intestine |
| extended release medication | released over a longer period, contains more drug |
| buccal | between cheek and gum |
| suppository | common dosage form used to administer meds via rectum |
| pharmacokinetics | physiological process of how the body acts on a drug (ADME) |
| bioavailability | amount of drug that is actually available in the body's tissues |
| first pass effect | occurs if drug is absorbed from the intestine into the liver before entering the systemic circulation |
| passive diffusion | lipid soluble drugs diffuse more quickly and easily and are capable of passing through blood brain barrier to affect cns |
| active transport | protein move drug across membrane |
| facilitated diffusion | drug selectivity through binding of a protein |
| onset of action | time it takes for drug to reach site of action |
| duration of action | period of time when concentration levels are sufficient enough to proeduce a therapeutic effect |
| metabolism | process by which drugs are inactivated and broken down into more water soluble metabolites in preparation for excretion |
| halflife | time it takes for concentration to be reduced by one half after it has reached peak concentration |
| elimination | process by which body rids itself of drug |
| pharmacodynamics | process of how drug acts on the body |
| agonist | drug that fits the receptor and initttates a mechanism similar to the endogenous compound |
| antagonist | drug that fits receptor but fails to initiate or block mechanism |
| receptor theory of drug action | agonists and antagonists |
| potency | strenght of drug |
| steady state | maintaing blood levels within the therapeutic range, achieved once the blood levesls from continued dosing matches the levls of excretion of a drug |
| agonistic interaction | 2 drugs of same type taken together to add and increase overall effect |
| antagonistic effects | 2 unrelated drugs to reduce effectivenss of oral drug |
| cox 1 (housekeeping) responsible for | gi mucosal integrity, platelet aggregation, renal function |
| cox 2 (inflamatory gene) responsible for | inflamation, pain, wound healing |
| penicilins, cephalosporins, and carbapenems | inhibit synthesis of bacterias cell wall (bactericidal antibiotics) |
| tetracyclines, macrolides, aminoglcosides | disrupt normal protein synthesis |
| sulonamides | inhibit an enzyme used to synthesize tetrahydrofolic acid within bacteria |
| staphylococcus aureus infection | misuse of antibiotics has lead to increased incidence of antibiotic resistancce |
| h1 histamine | respiratory tract |
| h2 histamine | stomach |
| h3 histamine | cerebrospinal fluid |
| 1st generation h1 antihistamine | lipid soluble, can cross blood brain barrier to affect cns (drowsiness) |
| 2nd gen antihistamine | less lipid soluble, not as drowsy, better for daytime |
| decongestants | cause vacoconstriction of the blood vessls within the nasal passages to help reduce swelling of mucous membranes |
| bronchodilators | used by individuals with asthma to relax bronchial spasms and expand airways |
| antiemetics | used to treat nausea and vomiting (regulated in medulla) |
| antidarrheals | used to treat symptoms of diarrhea, howerver don't generally treat underlying cause |
| bulk forming laxative | made of a fiber or cellulose that swells once combined with fluid producing a thick substance that stimulates perisatalsis and pushes the intestinal content forward |
| osmotic laxatives | function to increase peristalis by drawing water into the intestinal lumen |
| stimulant laxatives | increase motility of bowels |
| antacids | neutralize stomach acid and increase gastric pH |
| fungicidals | disrupt cell membrane of fungus thus killing the fungal cell, |
| fungistatics | prevent the fungal cell from replicating, allowing the immune system to mainage the infection |
| antiviral meds | used to treat herpes and influenza infections prevent and reduce duratin and severity of the virus |
| deep somatic pain | bone nerve muscle tendons ligaments arteries or joints |
| visceral pain | internal organs |
| hyperplasia | increase in nmber of cells in a tissue without chane in the rate of cell division or function (adaptaion to chronic increased metabolic demands) |
| metaplasia | replacement of cells of one type with antoher in response to physical or chemical irritants |
| dysplasia | cells adapt by changing to an abnormal cell type (cancer) |
| necrosis | cell death |
| proliferative stage | serves to close the tissue wond (scar) |
| remodeling stage | overlaps proliferative: some tissue remodeling occurs while collagein is still being deposited to heal the damage. stops when structure is restored |
| hyperpnea | rapid respiration |
| osteocytes | mature bone cells |
| osteoplats | produce osteocytes |
| osteoclats | resorbe osteocytes |
| osteomyelitis | inflammation of bone and bone marrow |
| arthritis | subtle joint instability and joint capsule inflammation |
| connective tissue | collagen and elastin. heals with collagen only, loses flexibility after injury |
| epithelium | lines int. ext surfaces of body |
| endothelium | lines cardiovasuclar system |
| hemorrhage | loss of large amounts of blood from vascular system |
| shock | organs become deprived of blood borne nutrients and oxygen |
| septicemia | presense of infection |
Created by:
jocbutch
Popular Sports Medicine sets